Published in HSS J on September 01, 2007
A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord (2013) 1.11
Unsatisfactory outcome of arthrodesis performed after septic failure of revision total knee arthroplasty. J Bone Joint Surg Am (2015) 0.78
The use of spacers (static and mobile) in infection knee arthroplasty. Curr Rev Musculoskelet Med (2015) 0.75
Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am (2007) 2.34
Articulating versus static spacers in revision total knee arthroplasty for sepsis. The Ranawat Award. Clin Orthop Relat Res (2000) 2.10
2-stage reimplantation for infected total knee replacement. Clin Orthop Relat Res (1996) 2.04
Two-stage reimplantation for the salvage of total knee arthroplasty complicated by infection. Further follow-up and refinement of indications. J Bone Joint Surg Am (1990) 1.88
The PROSTALAC functional spacer in two-stage revision for infected knee replacements. Prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg Br (2000) 1.70
Arthroscopic debridement in the treatment of the infected total knee replacement. J Bone Joint Surg Br (2004) 1.70
Treatment of infected total knee arthroplasty using an articulating spacer. Clin Orthop Relat Res (1995) 1.64
Two-stage reimplantation in infected total knee arthroplasty. Clin Orthop Relat Res (1988) 1.57
Comparison of a static with a mobile spacer in total knee infection. Clin Orthop Relat Res (2002) 1.53
Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg Am (2003) 1.48
The results of spacer block technique in revision of infected total knee arthroplasty. Clin Orthop Relat Res (1989) 1.28
Treatment of infected total knee arthroplasty. Irrigation and debridement versus two-stage reimplantation. J Arthroplasty (1990) 1.27
Infected total knee arthroplasty. A protocol for management. J Arthroplasty (1987) 1.20
Optimal timeframe for reporting short-term complication rates after total knee arthroplasty. J Arthroplasty (2006) 1.08
Bone loss associated with the use of spacer blocks in infected total knee arthroplasty. Clin Orthop Relat Res (1997) 1.07
Temporary articulating methylmethacrylate antibiotic spacer (TAMMAS). A new method of intraoperative manufacturing of a custom articulating spacer. J Bone Joint Surg Am (2001) 1.04
Techniques in arthroplasty. Use of an articulated PMMA spacer in the infected total knee arthroplasty. J Arthroplasty (1995) 1.01
A technique for intraoperative construction of antibiotic spacers. Clin Orthop Relat Res (2006) 0.93
Hand-made articulating spacers for infected total knee arthroplasty: a technical note. Acta Orthop (2006) 0.85
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. Med Sci Monit (2009) 1.01
The Genesis II in primary total knee replacement: a systematic literature review of clinical outcomes. Knee (2011) 0.87
L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis. Med Sci Monit (2013) 0.83
Does primary or secondary chondrocalcinosis influence long-term survivorship of unicompartmental arthroplasty? Clin Orthop Relat Res (2011) 0.81